Revenue
2.5 million USD
2023 Q3 · USD
Exact inputs and evidence
- Revenue: 2500311 USD Source
7 filing records in this dataset, filed from 2023-04-17 to 2024-03-18. Reported financial figures are available; chart coverage varies by period.
2.5 million USD
2023 Q3 · USD
-37.06%
2023 Q3 · %
-254 thousand USD
2023 Q3 · USD
-254 thousand USD
2023 Q3 · USD
77226355 shares
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-03-18.
Financial data available through: 2022-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 1.56 million
–
Current period
USD 4.09 million
–
4093212 − 1557375 = 2535837 USD
1557375 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source4093212 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 3.14 million
–
Current period
−USD 10.88 million
–
-10881122 − -3143480 = -7737642 USD
-3143480 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-10881122 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 1.2 million
–
Current period
−USD 833,452
–
-833452 − -1204401 = 370949 USD
-1204401 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-833452 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 1.94 million
–
Current period
USD 2.07 million
–
2068562 − 1939340 = 129222 USD
1939340 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source2068562 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | 1557375 | 4684954 Derived | -3127579 | 15901 Derived | -3143480 | -3143741 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 4093212 | 14922929 Derived | -10829717 | 51405 Derived | -10881122 | -2902014 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Revenue | 1557375 |
|
| 2022 | Revenue | 4093212 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | 162.8% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Operating margin | -200.8% |
|
| 2022 | Operating margin | -264.6% |
|
| 2021 | Net margin | -201.8% |
|
| 2022 | Net margin | -265.8% |
|
| 2021 | Free cash flow margin | -201.9% |
|
| 2022 | Free cash flow margin | -70.9% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Operating cash flow | -1204401 |
|
| 2022 | Operating cash flow | -833452 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Free cash flow | -3143741 |
|
| 2022 | Free cash flow | -2902014 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Liabilities / assets | 26.4% |
|
| 2022 | Liabilities / assets | 51.3% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Current assets / current liabilities | 11.9× |
|
| 2022 | Current assets / current liabilities | 0.98× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | −USD 3.14 million Exact valueExact value: -3143480 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.2 million Exact valueExact value: -1204401 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.94 million Exact valueExact value: 1939340 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.14 million Calculation and evidence-1204401 − 1939340 USD Exact free cash flow: -3143741 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 10.88 million Exact valueExact value: -10881122 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 833,452 Exact valueExact value: -833452 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.07 million Exact valueExact value: 2068562 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.9 million Calculation and evidence-833452 − 2068562 USD Exact free cash flow: -2902014 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
7 filings · 409 latest values · 409 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001844793, 1844793, edgar:1844793
Also known as YO-HEALTH, INC, YO-HEALTH, INC., Yo-Health Inc.